Banzai Reports Second Quarter 2025 Financial Results

(NASDAQ:BNZI), Revenue of $3.3 Million for Q2 2025, Representing 205% Growth from Q2 2024 Gross Profit of $2.7 Million for Q2 2025, Representing 267% Growth from Q2 2024; Gross Margin Expanded to 83.0% in Q2 2025 a 1390 BPS Increase Management to Host Second Quarter 2025 Results Conference Call Today, Thursday, August 14, 2025 at […]

Shimmick Corporation Announces Second Quarter 2025 Results

Shimmick Corporation Announces Second Quarter 2025 Results GlobeNewswire August 14, 2025 IRVINE, Ca., Aug. 14, 2025 (GLOBE NEWSWIRE) — Shimmick Corp. (NASDAQ: SHIM), a leading infrastructure solutions provider in water, climate resilience, energy transition and sustainable transportation, today announced financial results for the second quarter ended July 4, 2025. Second Quarter 2025 and Recent Highlights

IO Biotech Reports Second Quarter 2025 Financial Results and Provides Business Highlights

(NASDAQ:IOBT), Announced clinical improvement in progression free survival observed in pivotal Phase 3 Trial of Cylembio(R) plus KEYTRUDA(R) (pembrolizumab) for the treatment of first-line advanced melanoma, but statistical significance narrowly missed; company plans to meet with FDA this fall to discuss data and next steps for a potential regulatory submission Ended second quarter with approximately

Elutia Delivers Robust Growth on the Strength of EluPro(TM) Market Adoption

(NASDAQ:ELUT), EluPro(TM) Q2 revenue up 49% sequentially; Elutia advances next-generation drug-eluting biomatrix for breast reconstruction Conference call today at 5:00 p.m. ET / 2:00 p.m. PT GAITHERSBURG, Md., Aug. 14, 2025 (GLOBE NEWSWIRE) — Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today provided a business update and financial

RxSight, Inc. to Present at the Wells Fargo Healthcare Conference

(NasdaqGM:RXST), ALISO VIEJO, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) — RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Wells Fargo Healthcare Conference in Boston. RxSight's management is scheduled to present on Thursday, September 4, 2025, at 7:15

TILT Holdings Reports Second Quarter 2025 Results

(Neo:TILT.NE),(OTC US:TLLTF),(Other OTC:TLLTF),(Pinksheets:TLLTF),(PinkSheets:TLLTF), SCOTTSDALE, Ariz., Aug. 14, 2025 (GLOBE NEWSWIRE) — TILT Holdings Inc. (“TILT” or the “Company”) (Cboe CA: TILT) (OTCID: TLLTF), a global provider of cannabis business solutions including inhalation technologies, cultivation, manufacturing, processing, brand development and retail, announced its financial and operating results for the three months ended June 30, 2025. All

Cibus Reports Second Quarter Financial Results and Provides Year-to-Date Business Update for 2025

(NASDAQ:CBUS), Streamlining operational focus on Rice herbicide tolerance traits and partner-funded and/or supported programs, expected to reduce annual cash usage to approximately $30 million by 2026 Commercialization of Rice herbicide tolerance traits HT1 and HT3 on track – targeting an initial commercial launch in Latin America beginning in 2027 and expanding to the U.S. in

Profound Medical Announces Second Quarter 2025 Financial Results

(TSX:PRN),(NASDAQ:PROF), TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, AI-powered, incision-free therapies for the ablation of diseased tissue, today reported unaudited financial results for the second quarter ended June 30, 2025. Unless specified otherwise, all amounts in

TOMI Environmental Solutions, Inc. Reports Q2 2025 Financial Results and Outlines Growth Initiatives

(NASDAQ:TOMZ), FREDERICK, Md., Aug. 14, 2025 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a global provider of disinfection and decontamination essentials through its premier Binary Ionization Technology(R) (BIT(TM)) platform, today announced financial results for the quarter ended June 30, 2025, and provided an update on strategic initiatives designed to drive long-term growth. Q2

SL Green Realty Corp. to Present at the BofA Securities 2025 Global Real Estate Conference on September 10, 2025

(NYSE:SLG), NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) — SL Green Realty Corp. (NYSE: SLG), New York City's largest office landlord, today announced that Matt DiLiberto, Chief Financial Officer, Harrison Sitomer, Chief Investment Officer, and Steven Durels, Executive Vice President and Director of Leasing and Real Property, of SL Green, will participate in a roundtable

Scroll to Top